Are DENTSPLY SIRONA Inc (XRAY) shares trading below fair value?


Investors Observer gives DENTSPLY SIRONA Inc (XRAY) a solid evaluation score of 100 from its analysis. The proprietary rating system takes into account the underlying health of a company by analyzing its stock price, earnings and rate of growth. XRAY currently holds better value than 100% of the shares based on these metrics. Long-term buy and hold investors should find the most relevant valuation ranking system when making investment decisions.

XRAY achieves a valuation ranking of 100 today. Find out what this means to you and get the rest of the leaderboard on XRAY!

Metrics analysis

XRAY’s 12-month price-to-earnings (PE) ratio of 37.2 puts it above the all-time average of around 15. XRAY is poor value at its current trading price, as investors pay more than its current trading price. value in relation to the company’s profits. . XRAY’s last 12-month earnings per share (EPS) of 1.68 does not justify what it is currently trading in the market. However, follower PE ratios do not take into account a company’s projected growth rate, resulting in some companies having high PE ratios due to high growth potentially attractive to investors even though current earnings are weak. XRAY’s 12-month PE / Growth (PEG) ratio of 1 is considered to be roughly medium as the market values ​​XRAY in line with its projected earnings growth. XRAY’s PEG is derived from its forward price / earnings ratio divided by its growth rate. A PEG ratio of 1 represents a perfect correlation between earnings growth and the stock price. Due to their integration of more fundamentals of the overall health of a company and their focus on the future rather than the past, PEG ratios are one of the most widely used valuation measures by analysts today. ‘hui.


XRAY’s valuation metrics are adequate at its current price due to a fairly valued PEG ratio despite strong growth. XRAY’s PE and PEG are around the market average, resulting in an average valuation score. Click here for the full DENTSPLY SIRONA Inc (XRAY) stock report.

Leave A Reply

Your email address will not be published.